Compare RNA & CALX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RNA | CALX |
|---|---|---|
| Founded | 2012 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Telecommunications Equipment |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0B | 4.2B |
| IPO Year | 2020 | 2010 |
| Metric | RNA | CALX |
|---|---|---|
| Price | $72.39 | $51.68 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 20 | 5 |
| Target Price | $69.26 | ★ $77.75 |
| AVG Volume (30 Days) | ★ 2.1M | 763.6K |
| Earning Date | 02-26-2026 | 01-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $20,868,000.00 | ★ $933,685,000.00 |
| Revenue This Year | $57.30 | $21.58 |
| Revenue Next Year | $28.41 | $13.35 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 106.27 | 4.89 |
| 52 Week Low | $21.51 | $28.61 |
| 52 Week High | $72.61 | $71.22 |
| Indicator | RNA | CALX |
|---|---|---|
| Relative Strength Index (RSI) | 73.95 | 37.49 |
| Support Level | $72.04 | $52.49 |
| Resistance Level | $72.47 | $55.01 |
| Average True Range (ATR) | 0.21 | 1.49 |
| MACD | -0.21 | -0.07 |
| Stochastic Oscillator | 63.71 | 19.50 |
Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. Company's pipeline currently has three programs in potentially registrational clinical trials: DM1, FSHD, and DMD. The segments includes following: Del-zota for DMD44, Del-desiran for DM1, Del-brax for FSHD.
Calix Inc develops, markets and sells its appliance-based platform, cloud and managed services that enable service providers of all types and sizes to innovate and transform their businesses. The company's customers utilize the real-time data and insights from Calix platforms to simplify their business and deliver experiences that excite their subscribers. The resulting growth in subscriber acquisition, loyalty and revenue creates more value for their businesses and communities. The Company's revenue is principally derived in the United States and it also has its presence in Middle East & Africa, Europe, Asia Pacific and other markets.